Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 17/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.77 |
| ▸ | ADORA2A | P29274 | 13/20 | 0.64 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | ABL1 | P00519 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3064192 | 0.91 | ADORA2B (0.92) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3063823 | 0.91 | ADORA2B (0.68) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3077266 | 0.89 | ADORA2B (0.92) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| Las101057 SCHEMBL29941566 | 0.87 | ADORA2B (1.00) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| Las101057 SCHEMBL3075657 | 0.87 | ADORA2B (1.00) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3071385 | 0.82 | ADORA2B (0.72) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3073782 | 0.82 | ADORA2B (0.75) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3074836 | 0.80 | ADORA2B (0.74) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3064248 | 0.80 | ADORA2B (0.71) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 | |
| SCHEMBL3064297 | 0.79 | ADORA2B (0.84) | ADORA2BCYP3A4CYP2C19ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1922313-A1 | PYRAZINE DERIVATIVES USEFUL AS ADENOSINE RECEPTOR ANTAGONISTS | Laboratorios Almirall, S.A. (ES) | 2008-05-21 | — | — | EP | claimed |
| WO-2007017096-A1 | PYRAZINE DERIVATIVES USEFUL AS ADENOSINE RECEPTOR ANTAGONISTS | LABORATORIOS ALMIRALL, S.A. (ES) | 2007-02-15 | — | — | WO | claimed |